Hennion & Walsh Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663K | Sell |
27,351
-1,791
| -6% | -$43.4K | 0.03% | 591 |
|
|
2025
Q1 | $738K | Sell |
29,142
-7,192
| -20% | -$182K | 0.03% | 546 |
|
|
2024
Q4 | $964K | Sell |
36,334
-3,253
| -8% | -$86.3K | 0.04% | 472 |
|
|
2024
Q3 | $1.15M | Sell |
39,587
-5,256
| -12% | -$152K | 0.05% | 418 |
|
|
2024
Q2 | $1.25M | Buy |
44,843
+3,568
| +9% | +$99.8K | 0.06% | 372 |
|
|
2024
Q1 | $1.15M | Buy |
41,275
+5,682
| +16% | +$158K | 0.06% | 391 |
|
|
2023
Q4 | $1.02M | Buy |
35,593
+2,360
| +7% | +$67.9K | 0.06% | 402 |
|
|
2023
Q3 | $1.1M | Buy |
33,233
+9,223
| +38% | +$306K | 0.07% | 336 |
|
|
2023
Q2 | $881K | Buy |
24,010
+3,707
| +18% | +$136K | 0.05% | 395 |
|
|
2023
Q1 | $828K | Sell |
20,303
-5,223
| -20% | -$213K | 0.05% | 400 |
|
|
2022
Q4 | $1.31M | Sell |
25,526
-221
| -0.9% | -$11.3K | 0.08% | 285 |
|
|
2022
Q3 | $1.13M | Sell |
25,747
-30,214
| -54% | -$1.32M | 0.07% | 294 |
|
|
2022
Q2 | $2.93M | Sell |
55,961
-6,233
| -10% | -$327K | 0.18% | 145 |
|
|
2022
Q1 | $3.22M | Sell |
62,194
-1,620
| -3% | -$83.9K | 0.17% | 161 |
|
|
2021
Q4 | $3.77M | Sell |
63,814
-10,751
| -14% | -$635K | 0.19% | 149 |
|
|
2021
Q3 | $3.21M | Sell |
74,565
-21,363
| -22% | -$919K | 0.17% | 176 |
|
|
2021
Q2 | $3.76M | Sell |
95,928
-12,613
| -12% | -$494K | 0.2% | 131 |
|
|
2021
Q1 | $3.93M | Buy |
+108,541
| New | +$3.93M | 0.24% | 111 |
|